OSSIO Debuts Trimmable Fixation Nail

OSSIO Inc. has introduced the OSSIOfiber Threaded Trimmable Fixation Nail for extremity fracture fixation.

The Nails can be used in hand and wrist, foot and ankle, sports medicine, and pediatric procedures. The OSSIOfiber Threaded Trimmable Fixation Nails accommodate two distinct applications: One system covers fracture fixation in the extremities; the other system specifically covers hand and wrist fractures.

William Crawford, M.D, an orthopedic surgeon at Texas Orthopedic Associates in Fort Worth, was among the first to use the Nail, in an interphalangeal great toe joint fusion. He also used the new implant in a Lisfranc repair, first metatarsophalangeal joint fusion, and a calcaneal osteotomy.

“The instrumentation that comes with each implant makes customization simple and easy, because it enables the surgeon to trim the implant’s length, right there in the O.R., to accommodate each patient’s unique fixation requirements,” explained Dr. Crawford, who is also the team physician for Texas Christian University athletics. “The simplicity of offering one length that can be trimmed to size—and everything you need in one single-use, sterile pack—is a game changer for inventory management in surgical centers where storage space is limited, cutting down on both cost and complexity.”

Two orthopedic surgeons contributed to the Nails’ differentiated design, specifically for metacarpal fracture fixation: Meredith Osterman, M.D, with Philadelphia Hand to Shoulder Center; and Jerry Huang, M.D., a professor of orthopedic surgery and sports medicine and chief of orthopedic hand service at the University of Washington.

“Metacarpal fractures are common in younger, active patients, often from sports or falls,” Dr. Huang said. “Having a solution that integrates into the fractured bone over time—without the risks of long-term hardware retention—is a significant advancement in metacarpal fixation and key to restoring these patients’ mobility quickly. For surgeons, OSSIOfiber implants put to rest the potential nightmare of broken or stuck metal screws, which can be very challenging to remove.”

OSSIOfiber Threaded Trimmable Fixation Nails are 70mm long and are manufactured in two diameters— 4.5mm and 5.5mm. They also are packaged with a sterilized and disposable instrument pack.

“For patients, the thought of permanent metal in their hands is often unsettling. OSSIOfiber implants feature a unique material that mirrors bone properties, offering a solution that’s effective in both fixation and long-term integration into the body’s own anatomy,” Osterman stated. “They also leverage a technique every orthopedic surgeon already knows.”

OSSIOfiber implants use existing reimbursement codes and surgical techniques. All OSSIOfiber implants feature an advance in material science stronger than cortical bone, providing the first credible alternative to metal, absorbable and allograft fixation devices. With the potential to address an increasingly wide array of surgical applications due to the ease of manufacturing limitless variations, they are engineered to provide the strength required for functional fixation while allowing for full integration into patients’ native anatomy without adverse biological response.

Based on Intelligent Bone Regeneration Technology, OSSIOfiber implants combine mechanical strength and natural healing in a bio-integrative design. Their proprietary polymeric mineral fiber matrix propels rapid bone in-growth, regeneration and replacement—a new way for orthopedic surgeons to restore stability and mobility for their patients’ fractures while leaving nothing permanent behind.

“OSSIOfiber bio-integrative implants have been used in more than 40,000 orthopedic surgeries since our first launch in 2019,” OSSIO CEO Brian Verrier commented. “Over the last five years, we’ve brought 10 new product platforms to U.S. orthopedic surgeons, making OSSIOfiber implants applicable in dozens of surgical scenarios across upper and lower extremities, trauma, sports medicine, and pediatrics. We will continue to invest in our new product pipeline, which is driven by where we can add the greatest value to the patient and surgeon experience.”

OSSIO is an orthopedic fixation company committed to transforming the surgical experience for patients, physicians, providers, and payers. Founded in 2014, the company aims to provide the first credible replacement for metal implants in the global orthopedic fixation market with OSSIOfiber Intelligent Bone Regeneration Technology. OSSIO’s development team is based in Caesarea, Israel, and its commercial headquarters is in Woburn, Mass.